Alterity Therapeutics Ltd.ASX: ATH

Ph 2 Data Monitoring Committee Recommends Continuing Trial

Jul 26, 2023 at 4:07 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment